Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001243370 | SCV001416523 | likely benign | Duchenne muscular dystrophy | 2024-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402773 | SCV002711672 | uncertain significance | Cardiovascular phenotype | 2022-02-28 | criteria provided, single submitter | clinical testing | The p.I585S variant (also known as c.1754T>G), located in coding exon 15 of the DMD gene, results from a T to G substitution at nucleotide position 1754. The isoleucine at codon 585 is replaced by serine, an amino acid with dissimilar properties. Based on data from gnomAD, the G allele has an overall frequency of 0.003% (7/205369) total alleles studied, with 1 hemizygote observed. The highest observed frequency was 0.007% (2/28008) of Latino alleles. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003145473 | SCV003830061 | uncertain significance | not provided | 2023-09-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001835166 | SCV002092238 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-05-06 | no assertion criteria provided | clinical testing |